Compounding Pharmacy Recalls on the Rise
Reports of contaminated products manufactured by compounding pharmacies continue to rise as approximately 700 continue to suffer from a 2012 fungal meningitis outbreak linked to New England Compounding Center.
Recalls for Compounding Products Rising Drastically
- According to the Wall Street Journal, the FDA has already reported 14 multistate and nationwide recalls for products manufactured by compounding pharmacies this year.
- By comparison, the U.S. only saw two recalls in 2012 including the New England Compounding Center recall. The FDA reported no compounding pharmacy recalls four years prior to that.
- The most significant compounding pharmacy recall of this year has been that by Specialty Compounding LLC.
- Specialty Compounding LLC recalled all of its sterile products after 17 Corpus Christi patients who received calcium gluconate infections manufactured by the company developed blood stream infections.
14,000 Received Injections Contaminated with Fungus
- The Centers for Disease Control and Prevention reports that approximately 14,000 patients have received injection contaminated with the fungus exserohilum rostratum since September, 2012.
- Of those who received tainted injections 700 people have fallen ill.
- This year saw 86 new diagnoses while hundreds remain in treatment.
- Thus far, 64 patients have died as a result of the tainted injections – 24 so far for 2013.
Death is not the Only Concern Linked to Fungal Meningitis
“Her biggest fear is if she’ll ever be able to get her life going again – and nobody knows.” – Cathy Maccoux, mother of fungal meningitis victim as published by the Wall Street Journal.
- While preventing death is the primary concern for doctors working find viable treatments for the outbreak, patients are facing other struggles as well.
- Bob Pinkstaff who received a tainted steroid injection for back pain is now on medication that causes him to sweat so profusely that he must change t-shirts multiple times a day. His eyes are now hypersensitive to the point that he must wear sunglasses when watching television.
- Traci Maccoux, 23, has spent 40 nights in the hospital and accumulated over $430,000 in medical bills after being diagnosed with fungal meningitis last year. Ms. Mccoux has also had to reduce her college attendence.
- The outbreak has been so severe that U.S. Congress is working on a bill that will give the Food and Drug Administration the authority to regulate compounding pharmacies nationwide.
Contact an Experienced Product Liability Attorney
Thomas J. Henry are leaders in the area of drug and product liability litigation. Our Defective Drug and Products Division have extensive knowledge and resources in order to represent our clients efficiently and aggressively. The Defective Drug and Products Division represent a multitude of people who are battling against manufacturers of medical devices and/ or defective pharmaceuticals.
If you or a loved one have been injured by or have developed serious side-effects from the use of defective medications or pharmaceuticals, contact Thomas J. Henry immediately. We represent clients/victims all over the country. We are available 24/7, nights and weekends.
RECENT CLINICAL DRUG TRIAL RESULT
$7.2 MillionExpenses: $24,838.25 | Attorneys Fees: $2,200,000.00 | Net to Client: $3,275,161.75 (Purchase of a Lifetime Annuity)
RECENT CLINICAL DRUG TRIAL RESULT
$4 MillionExpenses: $24,856.98 | Attorneys Fees: $1,600,000.00 | Net to Client: $2,375,143.02